Bristol-Myers Squibb (BMY) Board Provides Open Letter Shareholder Regarding Merger Agreement with Celgene Corp. (CELG)

March 25, 2019 7:02 AM
Bristol-Myers Squibb Company’s (NYSE: BMY) Board of Directors today sent an open letter to the Company’s shareholders regarding the previously ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)


Corporate News Management Comments Mergers and Acquisitions

Next Articles